• Determination of candesartan or olmesartan in hypertensive patient plasma using UPLC-MS/MS

• Jeong Hyeon-Cheol

• Seo Yo-Han, Gu Nam-Yi, Rhee Moo-Yong, Shin Kwang-Hee

• Translational and Clinical Pharmacology   2021  Volume.29  No.4 226 ~ 238

• A validated simple LC-MS/MS method for quantifying trimethylamine N-oxide (TMAO) using a surrogate m...

• Li Yufei

• Kang Ji-Hyun, Lee Yu-Jin, Chung Jae-Yong, Cho Joo-Youn

• Translational and Clinical Pharmacology   2021  Volume.29  No.4 216 ~ 225

• Medication selection for the treatment of acute infective diarrhea in Thai pharmacies: a qualitative...

• Leelakanok Nattawut

• Petchsomrit Arpa, Methaneethorn Janthima, Pornwattanakavee Suphannika Prateepjarassaeng

• Translational and Clinical Pharmacology   2021  Volume.29  No.4 206 ~ 215

• QTc prolongation in patients with COVID-19: a retrospective chart review

• Pornwattanakavee Suphannika Prateepjarassaeng

• Priksri Watcharapong, Leelakanok Nattawut

• Translational and Clinical Pharmacology   2021  Volume.29  No.4 197 ~ 205

• Trends of clinical trials from 2017 to 2019 in Korea: an integrated analysis based on the Ministry o...

• Huh Ki-Young

• Yu Kyung-Sang, Lim Hyeong-Seok, Kim Hyung-Sub

• Translational and Clinical Pharmacology   2021  Volume.29  No.4 186 ~ 196

• Clinical development and trial operations in COVID-19 era

• Choe Seong-Choon

• Translational and Clinical Pharmacology   2021  Volume.29  No.4 181 ~ 185